Since founded in March 2020, Shanghai Vitalgen BioPharma Co., Ltd. (Vitalgen) has committed to translating cutting edge discoveries and technologies in cell and gene therapy into clinically effective treatments for patients with unmet medical needs.
Vitalgen has a team of leading academic researchers and seasoned R&D executives with extensive drug discovery experience from scientific concepts to marketed drugs. By applying proprietary ViVec® AAV capsids, ViLNP® lipid nanoparticles, ViCas® novel CRISPR/Cas editing tools and ViHiYi® high yield/high fidelity AAV production system, we are committed to developing innovative cell and gene therapies for the treatment of hereditary diseases, neurodegenerative diseases and cancers for local and global markets.
Address: Building 2，No.11 Jialilue Road, Pudong New District, Shanghai, China
Copyright © 2022 Shanghai Vitalgen BioPharma Co., Ltd All Rights Reserved. 沪ICP备22000000号